GENERAL DISCUSSION 231 10 112. deVriesT,Villalón CM,MaassenVanDenBrink A. Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans. Pharmacol Ther. 2020;211:107528. 113. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996;87(3):543-552. 114. Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005;366(9483):371-377. 115. De Fusco M, Marconi R, Silvestri L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet. 2003;33(2):192-196. 116. Choquet H, Yin J, Jacobson AS, et al. New and sex-specific migraine susceptibility loci identified from a multiethnic genome-wide meta-analysis. Commun Biol. 2021;4(1):864. 117. Santiago JA, Potashkin JA. Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson’s disease. Proc Natl Acad Sci U S A. 2015;112(7):2257-2262. 118. Kotelnikova E, Shkrob MA, Pyatnitskiy MA, Ferlini A, Daraselia N. Novel approach to meta-analysis of microarray datasets reveals muscle remodeling-related drug targets and biomarkers in Duchenne muscular dystrophy. PLoS Comput Biol. 2012;8(2):e1002365. 119. García-Campos MA, Espinal-Enríquez J, Hernández-Lemus E. Pathway Analysis: State of the Art. Front Physiol. 2015;6:383. 120. Mavaddat N, Michailidou K, Dennis J, et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am J Hum Genet. 2019;104(1):21-34. 121. Kogelman LJA, Esserlind A-L, Francke Christensen A, et al. Migraine polygenic risk score associates with efficacy of migraine-specific drugs. Neurology Genetics. 2019;5(6):e364. 122. Lee KJ, Lee SJ, Bae HJ, Sung J. Exploring the causal inference of migraine on stroke: A Mendelian randomization study. Eur J Neurol. 2022;29(1):335-338. 123. Shu MJ, Li JR, Zhu YC, Shen H. Migraine and Ischemic Stroke: A Mendelian Randomization Study. Neurol Ther. 2021;11(1):237-246. 124. Daghals I, Sargurupremraj M, Danning R, et al. Migraine, Stroke, and Cervical Arterial Dissection: Shared Genetics for a Triad of Brain Disorders With Vascular Involvement. Neurol Genet. 2022;8(1):e653. 125. Siewert KM, Klarin D, Damrauer SM, et al. Cross-trait analyses with migraine reveal widespread pleiotropy and suggest a vascular component to migraine headache. Int J Epidemiol. 2020;49(3):1022-1031. 126. Guo Y, Rist PM, Daghlas I, et al. A genomewide cross-phenotype meta-analysis of the association of blood pressure with migraine. Nat Commun. 2020;11(1):3368. 127. Daghlas I, Guo Y, Chasman DI. Effect of genetic liability to migraine on coronary artery disease and atrial fibrillation: a Mendelian randomization study. Eur J Neurol. 2020;27(3):550-556. 128. Yuan S, Daghlas I, Larsson SC. Alcohol, coffee consumption,and smoking in relation to migraine: a bidirectional Mendelian randomization study. Pain. 2022;163(2):e342-e348. 129. Johnsen MB, Winsvold BS, Børte S, et al. The causal role of smoking on the risk of headache. A Mendelian randomization analysis in the HUNT study. Eur J Neurol. 2018;25(9):1148e102. 130. Ferrari A, Zappaterra M, Righi F, et al. Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey. J Headache Pain. 2013;14:48. 131. Lund N, Petersen A, Snoer A, Jensen RH, Barloese M. Cluster headache is associated with unhealthy lifestyle and lifestyle-related comorbid diseases: Results from the Danish Cluster Headache Survey. Cephalalgia. 2019;39(2):254-263. 132. May A, Schwedt TJ, Magis D, et al. Cluster headache. Nat Rev Dis Primers. 2018;4:18006. 133. Schurks M, Kurth T, de Jesus J, et al. Cluster headache: clinical presentation, lifestyle features, and medical treatment. Headache. 2006;46(8):1246-1254.
RkJQdWJsaXNoZXIy MTk4NDMw